This receptor was also not modulated by usual opiate agonists, which contain morphine, fentanyl, buprenorphine, or antagonists like naloxone. In an incredibly rat product, it had been identified that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3’s inhibitory action, triggering an Whole Improve in opiate receptor work out.